$VKTX is seen as an emerging challenger in the Obesity-Drug market and has had a very strong 12 months, from $8 to $75 now, reaching a peak at $100 in Feb.
Promising results continue to flow from their clinical trials too.
I have Wave 4 complete now....it was a strong pull back but likely due to the aggressive Wave 3 running so quickly.
Wave 5 target is at the 1 Fib at $137.